Lyn is a seasoned executive in global healthcare and IVD markets. Prior to joining Premaitha, Lyn was Group CEO at British Biocell International (now BBI Group) for over 9 years.
He began that role at BBI Group following the acquisition of BBI Holdings by Alere in 2008 and in his time, he oversaw the doubling of revenue growth and has developed an accountable and highly effective senior management team with clear focus on innovation, commercial delivery, compliance and operational efficiency. Lyn has completed 7 acquisitions during his tenure at BBI Group, all of which have been successfully integrated. He founded BBI Detection and BBI Animal Health and has demonstrated a strong track record of organic and acquisitive growth.
Before this role, he spent several years as the Managing Director and founder of BBI Healthcare in 2006 following the successful purchase of the GlucoGel product. He first began his business career as the European Marketing Manager at Shimano Europe BV. Lyn holds a degree in Business Studies from the University of Wales.